Duramed Receives Patent for Tablet Composition of Estrogen/Progestin Product

The US Patent and Trademark Office has granted Duramed Pharmaceuticals Inc. (Cincinnati) a patent for the composition of Cenestin (synthetic conjugated estrogens, A) Tablets and solid oral dose pharmaceutical products containing synthetic conjugated estrogens, A in combination with a progestin...
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news